$223.00
0.55%
NYSE, Mar 28, 09:10 pm CET
ISIN
IE00BFY8C754
Symbol
STE

Steris Stock price

$223.00
+3.74 1.71% 1M
-19.54 8.06% 6M
+17.44 8.48% YTD
-1.82 0.81% 1Y
-20.49 8.42% 3Y
+83.01 59.30% 5Y
+152.62 216.85% 10Y
NYSE, Closing price Fri, Mar 28 2025
-1.23 0.55%
ISIN
IE00BFY8C754
Symbol
STE
Sector

Key metrics

Market capitalization $21.91b
Enterprise Value $24.09b
P/E (TTM) P/E ratio 47.29
EV/FCF (TTM) EV/FCF 32.16
EV/Sales (TTM) EV/Sales 4.46
P/S ratio (TTM) P/S ratio 4.06
P/B ratio (TTM) P/B ratio 3.41
Dividend yield 1.00%
Last dividend (FY25) $2.23
Revenue growth (TTM) Revenue growth -0.17%
Revenue (TTM) Revenue $5.40b
EBIT (operating result TTM) EBIT $962.69m
Free Cash Flow (TTM) Free Cash Flow $749.09m
Cash position $155.18m
EPS (TTM) EPS $4.72
P/E forward 32.95
P/S forward 4.02
EV/Sales forward 4.42
Short interest 1.52%
Show more

Is Steris a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Steris Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Steris forecast:

4x Buy
57%
3x Hold
43%

Analyst Opinions

7 Analysts have issued a Steris forecast:

Buy
57%
Hold
43%

Financial data from Steris

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
5,398 5,398
0% 0%
100%
- Direct Costs 3,051 3,051
0% 0%
57%
2,347 2,347
0% 0%
43%
- Selling and Administrative Expenses 789 789
6% 6%
15%
- Research and Development Expense 107 107
2% 2%
2%
1,451 1,451
3% 3%
27%
- Depreciation and Amortization 488 488
15% 15%
9%
EBIT (Operating Income) EBIT 963 963
14% 14%
18%
Net Profit 468 468
18% 18%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Steris directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Steris Stock News

Positive
Seeking Alpha
9 days ago
Upgraded Steris to 'strong buy' with a fair value of $254 per share due to strong recovery in its Applied Sterilization Technologies (AST) business. AST segment showed 9.5% organic growth, with management confident in further recovery despite challenges from rising labor costs and raw material inflation. For FY25, Steris guides for 6% revenue growth and 3.1% adjusted EPS growth, with significan...
Neutral
Seeking Alpha
about 2 months ago
STERIS plc (NYSE:STE ) Q3 2025 Earnings Conference Call February 6, 2025 9:00 AM ET Company Participants Julie Winter – Investor Relations Mike Tokich – Senior Vice President and Chief Financial Officer Dan Carestio – President and Chief Executive Officer Conference Call Participants Jacob Johnson – Stephens Brett Fishbin – KeyBanc Michael Polark – Wolfe Research Jason Bednar – Piper Sandler Pa...
Negative
Reuters
about 2 months ago
Medical equipment maker Steris lowered its annual profit forecast on Wednesday, citing the impact of a stronger dollar.
More Steris News

Company Profile

STERIS Plc (Ireland) engages in the manufacture of medical and surgical equipment. The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.

Head office Ireland
CEO Daniel Carestio
Employees 18,179
Founded 2016
Website www.steris.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today